
Sanofi has continued to make progress in the development of Icaria (isatuximab), with the company announcing that the therapy met …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

